Current Medical Science-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2025-12-04 ms8000002977722178 来自北京

是SCI期刊
设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。
重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。
据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2023-10-30 ms6000002003586507 来自上海

请问Reviewers Assigned一般要多久会有回复吗？谢谢

133 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2025-11-02 换个ID能躺赢吗来自浙江省

这个杂志Under review后会变成什么状态呀

10 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2025-10-03 换个ID能躺赢吗来自浙江省

请问Reviewers Assigned一般要多久会有回复吗？谢谢

11 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2024-06-05 ms1000000562368627 来自广东省

审稿速度:1.0
经验分享：无

159 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2022-08-26 583215002_49469367

审稿速度:12.0 | 投稿命中率:50.0
经验分享：不容易找审稿人

0 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2023-10-26 misskenshion 来自上海

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：胎儿医学
经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2020-05-21 kissnicky

请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表:
请问你的文章一审最后花了多长时间？我的已经六个月了

133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了

292 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2018-10-12 zzsllokyy

我已经投稿半年多了，每次问都说还在外审。

412 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291880, encodeId=4220229188002, content=是SCI期刊 设有原创论文、综述文章栏目，不定期增设专题、专栏，也接收读者来信、评论、病例报告等类型的稿件，适配不同研究成果的投稿需求。 重点征稿方向是：涵盖基础医学（如生理学、生物化学、分子生物学等）、临床医学（如外科、内科、妇产科等）、公共卫生、法医学、药学与中医药学、医药卫生管理等。 据说今年代谢疾病方向，聚焦代谢疾病的机制探索、临床创新及防治策略比较热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722178, createdTime=Thu Dec 04 22:19:48 CST 2025, time=2025-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2165739, encodeId=63012165e39ae, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa035697859, createdName=ms6000002003586507, createdTime=Mon Oct 30 14:26:17 CST 2023, time=2023-10-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2287226, encodeId=df60228e2260e, content=这个杂志Under review后会变成什么状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Sun Nov 02 20:09:36 CST 2025, time=2025-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2283597, encodeId=d9d8228359e71, content=请问Reviewers Assigned一般要多久会有回复吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=26825512227, createdName=换个ID能躺赢吗, createdTime=Fri Oct 03 22:45:17 CST 2025, time=2025-10-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2208534, encodeId=235f2208534f7, content=审稿速度:1.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a29334839, createdName=ms1000000562368627, createdTime=Wed Jun 05 22:43:09 CST 2024, time=2024-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241180, encodeId=0426124118086, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：不容易找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05712536975, createdName=583215002_49469367, createdTime=Fri Aug 26 16:27:55 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165091, encodeId=9320216509167, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：胎儿医学 经验分享：审稿非常慢！编辑不回邮件，想撤稿都不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhaFfytmbiahDlUVXq5CXGrgibS27fwVb6ia8ITVTC0u2tIQnjz2jJZVia8v5w5YMtUq7FdYE7uOPlt5l/0, createdBy=2acd1616998, createdName=misskenshion, createdTime=Thu Oct 26 20:15:14 CST 2023, time=2023-10-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=591443, encodeId=c4e759144303, content=请问这个杂志是SCI吗133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, beContent=133****3348暂无昵称 2020-05-19 00:00:00 发表: 请问你的文章一审最后花了多长时间？我的已经六个月了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAQhls4o4vCbRhMibjOMCHuCpHk8yK4XIDyCViaxZt54of49hySMaWricB5IpNzPZkXBVhiaOlMsbRgg/132, createdBy=76dc2461344, createdName=kissnicky, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561934, encodeId=a09a56193468, content=我已经投稿半年多了，每次问都说还在外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15bc1977370, createdName=zzsllokyy, createdTime=Fri Oct 12 21:52:00 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059332, encodeId=44dd1059332d7, content=请问接收多久可以发表啊？这都俩月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpYzTTyoAK2Q6F5XXI1qhrejV4CgL4icCvkDbFo0uOKVibxlBWn1HSJJeEJb5Gc0yUlclmFN8eAafg/132, createdBy=68ed5214981, createdName=446147195_70413606, createdTime=Mon Oct 11 08:16:13 CST 2021, time=2021-10-11, status=1, ipAttribution=)]

2021-10-11 446147195_70413606

请问接收多久可以发表啊？这都俩月了

168 3 举报

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务